List of Tables
    Table 1. Key Players of Rheumatoid Arthritis (RA) Medications in Global Market
    Table 2. Top Rheumatoid Arthritis (RA) Medications Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Rheumatoid Arthritis (RA) Medications Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Rheumatoid Arthritis (RA) Medications Revenue Share by Companies, 2017-2022
    Table 5. Global Rheumatoid Arthritis (RA) Medications Sales by Companies, (K Units), 2017-2022
    Table 6. Global Rheumatoid Arthritis (RA) Medications Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Rheumatoid Arthritis (RA) Medications Price (2017-2022) & (K USD/Unit)
    Table 8. Global Manufacturers Rheumatoid Arthritis (RA) Medications Product Type
    Table 9. List of Global Tier 1 Rheumatoid Arthritis (RA) Medications Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Rheumatoid Arthritis (RA) Medications Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Target – Global Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Target - Global Rheumatoid Arthritis (RA) Medications Revenue (US$, Mn), 2017-2022
    Table 13. By Target - Global Rheumatoid Arthritis (RA) Medications Revenue (US$, Mn), 2023-2028
    Table 14. By Target - Global Rheumatoid Arthritis (RA) Medications Sales (K Units), 2017-2022
    Table 15. By Target - Global Rheumatoid Arthritis (RA) Medications Sales (K Units), 2023-2028
    Table 16. By Application – Global Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Rheumatoid Arthritis (RA) Medications Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Rheumatoid Arthritis (RA) Medications Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Rheumatoid Arthritis (RA) Medications Sales (K Units), 2017-2022
    Table 20. By Application - Global Rheumatoid Arthritis (RA) Medications Sales (K Units), 2023-2028
    Table 21. By Region – Global Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Rheumatoid Arthritis (RA) Medications Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Rheumatoid Arthritis (RA) Medications Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Rheumatoid Arthritis (RA) Medications Sales (K Units), 2017-2022
    Table 25. By Region - Global Rheumatoid Arthritis (RA) Medications Sales (K Units), 2023-2028
    Table 26. By Country - North America Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Rheumatoid Arthritis (RA) Medications Sales, (K Units), 2017-2022
    Table 29. By Country - North America Rheumatoid Arthritis (RA) Medications Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Rheumatoid Arthritis (RA) Medications Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Rheumatoid Arthritis (RA) Medications Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Rheumatoid Arthritis (RA) Medications Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Rheumatoid Arthritis (RA) Medications Sales, (K Units), 2023-2028
    Table 38. By Country - South America Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Rheumatoid Arthritis (RA) Medications Sales, (K Units), 2017-2022
    Table 41. By Country - South America Rheumatoid Arthritis (RA) Medications Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Medications Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Medications Sales, (K Units), 2023-2028
    Table 46. AbbVie Corporate Summary
    Table 47. AbbVie Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 48. AbbVie Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 49. Pfizer Corporate Summary
    Table 50. Pfizer Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 51. Pfizer Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 52. Boehringer Ingelheim Corporate Summary
    Table 53. Boehringer Ingelheim Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 54. Boehringer Ingelheim Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 55. Bayer Corporate Summary
    Table 56. Bayer Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 57. Bayer Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 58. Novartis Corporate Summary
    Table 59. Novartis Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 60. Novartis Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 61. Regeneron Pharmaceuticals Corporate Summary
    Table 62. Regeneron Pharmaceuticals Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 63. Regeneron Pharmaceuticals Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 64. Bristol-Myers Squibb Corporate Summary
    Table 65. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 66. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 67. Roche Corporate Summary
    Table 68. Roche Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 69. Roche Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 70. UCB S.A. Corporate Summary
    Table 71. UCB S.A. Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 72. UCB S.A. Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 73. Johnson & Johnson Corporate Summary
    Table 74. Johnson & Johnson Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 75. Johnson & Johnson Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 76. Amgen Corporate Summary
    Table 77. Amgen Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 78. Amgen Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 79. Merck Corporate Summary
    Table 80. Merck Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 81. Merck Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 82. Mitsubishi Tanabe Pharma Corporate Summary
    Table 83. Mitsubishi Tanabe Pharma Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 84. Mitsubishi Tanabe Pharma Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 85. Biogen Corporate Summary
    Table 86. Biogen Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 87. Biogen Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 88. Sanofi Corporate Summary
    Table 89. Sanofi Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 90. Sanofi Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 91. Alder Corporate Summary
    Table 92. Alder Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 93. Alder Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 94. Ablynx Corporate Summary
    Table 95. Ablynx Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 96. Ablynx Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 97. AstraZeneca Corporate Summary
    Table 98. AstraZeneca Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 99. AstraZeneca Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 100. Incyte Corporate Summary
    Table 101. Incyte Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 102. Incyte Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 103. Galapagos Corporate Summary
    Table 104. Galapagos Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 105. Galapagos Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 106. Hanwha Biologics Corporate Summary
    Table 107. Hanwha Biologics Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 108. Hanwha Biologics Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 109. CPGJ Corporate Summary
    Table 110. CPGJ Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 111. CPGJ Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 112. Celgen Pharm Corporate Summary
    Table 113. Celgen Pharm Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 114. Celgen Pharm Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 115. Hisun Corporate Summary
    Table 116. Hisun Rheumatoid Arthritis (RA) Medications Product Offerings
    Table 117. Hisun Rheumatoid Arthritis (RA) Medications Sales (K Units), Revenue (US$, Mn) and Average Price (K USD/Unit) (2017-2022)
    Table 118. Rheumatoid Arthritis (RA) Medications Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 119. Global Rheumatoid Arthritis (RA) Medications Capacity Market Share of Key Manufacturers, 2020-2022
    Table 120. Global Rheumatoid Arthritis (RA) Medications Production by Region, 2017-2022 (K Units)
    Table 121. Global Rheumatoid Arthritis (RA) Medications Production by Region, 2023-2028 (K Units)
    Table 122. Rheumatoid Arthritis (RA) Medications Market Opportunities & Trends in Global Market
    Table 123. Rheumatoid Arthritis (RA) Medications Market Drivers in Global Market
    Table 124. Rheumatoid Arthritis (RA) Medications Market Restraints in Global Market
    Table 125. Rheumatoid Arthritis (RA) Medications Raw Materials
    Table 126. Rheumatoid Arthritis (RA) Medications Raw Materials Suppliers in Global Market
    Table 127. Typical Rheumatoid Arthritis (RA) Medications Downstream
    Table 128. Rheumatoid Arthritis (RA) Medications Downstream Clients in Global Market
    Table 129. Rheumatoid Arthritis (RA) Medications Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Rheumatoid Arthritis (RA) Medications Segment by Target
    Figure 2. Rheumatoid Arthritis (RA) Medications Segment by Application
    Figure 3. Global Rheumatoid Arthritis (RA) Medications Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Rheumatoid Arthritis (RA) Medications Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Rheumatoid Arthritis (RA) Medications Revenue, 2017-2028 (US$, Mn)
    Figure 7. Rheumatoid Arthritis (RA) Medications Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Rheumatoid Arthritis (RA) Medications Revenue in 2021
    Figure 9. By Target - Global Rheumatoid Arthritis (RA) Medications Sales Market Share, 2017-2028
    Figure 10. By Target - Global Rheumatoid Arthritis (RA) Medications Revenue Market Share, 2017-2028
    Figure 11. By Target - Global Rheumatoid Arthritis (RA) Medications Price (K USD/Unit), 2017-2028
    Figure 12. By Application - Global Rheumatoid Arthritis (RA) Medications Sales Market Share, 2017-2028
    Figure 13. By Application - Global Rheumatoid Arthritis (RA) Medications Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Rheumatoid Arthritis (RA) Medications Price (K USD/Unit), 2017-2028
    Figure 15. By Region - Global Rheumatoid Arthritis (RA) Medications Sales Market Share, 2017-2028
    Figure 16. By Region - Global Rheumatoid Arthritis (RA) Medications Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Rheumatoid Arthritis (RA) Medications Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Rheumatoid Arthritis (RA) Medications Sales Market Share, 2017-2028
    Figure 19. US Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Rheumatoid Arthritis (RA) Medications Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Rheumatoid Arthritis (RA) Medications Sales Market Share, 2017-2028
    Figure 24. Germany Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 25. France Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Rheumatoid Arthritis (RA) Medications Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Rheumatoid Arthritis (RA) Medications Sales Market Share, 2017-2028
    Figure 33. China Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 37. India Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Rheumatoid Arthritis (RA) Medications Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Rheumatoid Arthritis (RA) Medications Sales Market Share, 2017-2028
    Figure 40. Brazil Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Medications Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Rheumatoid Arthritis (RA) Medications Sales Market Share, 2017-2028
    Figure 44. Turkey Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Rheumatoid Arthritis (RA) Medications Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Rheumatoid Arthritis (RA) Medications Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Rheumatoid Arthritis (RA) Medications by Region, 2021 VS 2028
    Figure 50. Rheumatoid Arthritis (RA) Medications Industry Value Chain
    Figure 51. Marketing Channels